Syneron to Participate in Two Upcoming Investor Conferences
Syneron Medical Ltd.
(NASDAQ: ELOS), the leading global aesthetic device company, announced today that Company management is scheduled to participate at two upcoming investor conferences.
(Logo: http://photos.prnewswire.com/prnh/20120528/535447) The first conference is the Leerink Swann November Management Access Days in Boston. This conference will allow institutional investors to meet with Syneron but does not include a formal presentation. Louis P.
Scafuri, Chief Executive Officer, will attend on behalf of Syneron.
Conference: Leerink Swann November Management Access Days Date: Tuesday, November 20, 2012 The second conference is the Canaccord Genuity Medical Technology & Diagnostics Forum in New York City. Louis P. Scafuri, Chief Executive Officer, and Hugo Goldman, Chief Financial Officer, will attend on behalf of Syneron.
Conference: Canaccord Genuity Medical Technology & Diagnostics Forum Date Tuesday, December 4, 2012 Time: 9:30 a.m. ET The Canaccord conference presentation will be webcast live over the Internet and can be accessed through the Investor Relations section on Syneron's website at www.investors.syneron.com. Please go to the website a few minutes early, as it may be necessary to download audio software to hear the presentation.
About Syneron Medical Ltd. Syneron Medical Ltd. (NASDAQ: ELOS) is the leading global aesthetic device company with a comprehensive product portfolio and a global distribution footprint. The Company's technology enables physicians to provide advanced solutions for a broad range of medical-aesthetic applications including body contouring, hair removal, wrinkle reduction, rejuvenation of the skin's appearance through the treatment of superficial benign vascular and pigmented lesions, and the treatment of acne, leg veins and cellulite. The Company sells its products under two distinct brands, Syneron and Candela. Founded in 2000, the corporate, R&D, and manufacturing headquarters for Syneron Medical Ltd. are located in Israel. Syneron also has R&D and manufacturing operations in the US.
The Company markets, services and supports its products in 90 countries. It has offices in North America, France, Germany, Italy, Portugal, Spain, UK, Australia, China, Japan, and Hong Kong and distributors worldwide.
SOURCE Syneron Medical Ltd.
-0- 11/15/2012 /CONTACT: Hugo Goldman, Chief Financial Officer, email@example.com; or Zack Kubow, The Ruth Group, +1-646-536-7020, firstname.lastname@example.org /Photo: http://photos.prnewswire.com/prnh/20120528/535447 PRN Photo Desk, email@example.com /Web Site: http://www.syneron-candela.com (NASDAQ-NMS:ELOS) / CO: Syneron Medical Ltd.
ST: Israel Massachusetts New York IN: HEA MEQ MTC SU: CCA PRN -- NY14280 -- 0000 11/15/2012 21:15:00 EDT http://www.prnewswire.c